Table 2.
Association between the proliferative lesions of Brunner's gland and the variables.
| Variables | Type of the Proliferative Lesion of BG a | Statistical result | ||||
| Hamartoma | Hyperplasia | |||||
| n | % | n | % | p b | ||
|
| ||||||
| Gender | Female | 4 | 80 | 5 | 38.46 | 0.294 |
| Male | 1 | 20 | 8 | 61.54 | ||
| Gastritis Status | Chronic gastritis | 3 | 60 | 8 | 61.54 | 0.676 |
| Active chronic gastritis | 2 | 40 | 5 | 38.46 | ||
| Lymphoid Hyperplasia | No | 3 | 60 | 11 | 84.62 | 0.533 |
| Yes | 2 | 40 | 2 | 15.38 | ||
| Foveolar Hyperplasia | No | 5 | 100 | 12 | 92.31 | 0.722 |
| Yes | 0 | 0 | 1 | 7.69 | ||
| Gastric Mucosa Inflammation | No | 0 | 0 | 0 | 0 | - |
| Yes | 5 | 100 | 13 | 100 | ||
| Gastric Mucosa Activation | No | 3 | 60 | 6 | 46.15 | 0.5 |
| Yes | 2 | 40 | 7 | 53.85 | ||
| Gastric Mucosa Metaplasia | No | 4 | 80 | 13 | 100 | 0.278 |
| Yes | 1 | 20 | 0 | 0 | ||
| Gastric Mucosa Atrophy | No | 4 | 80 | 13 | 100 | 0.278 |
| Yes | 1 | 20 | 0 | 0 | ||
| Gastric Mucosa H. pylori d | No | 2 | 40 | 4 | 30.77 | 0.561 |
| Yes | 3 | 60 | 9 | 69.23 | ||
| Duodenitis Status |
Chronic duodenitis | 5 | 100 | 11 | 84.62 | 0.51 |
| Active chronic duodenitis | 0 | 0 | 2 | 15.38 | ||
| Site of the Proliferative Lesion of BG | Anterior bulbus | 4 | 80 | 3 | 23.08 | 0.046 |
| Posterior bulbus | 1 | 20 | 2 | 15.38 | ||
| On both sides | 0 | 0 | 8 | 61.54 | ||
|
| ||||||
| Variables | Type of the Proliferative Lesion of BG | |||||
| n | Mean Min. Max. | SD e | p c | |||
|
| ||||||
| Age | BG hamartoma | 5 | 68.6 52 85 | 11.93 | 0.002 | |
| BG hyperplasia | 13 | 40.92 16 63 | 13.97 | |||
| Lesion diameter (mm) | BG hamartoma | 5 | 12.8 5 30 | 9.88 | 0.0001 | |
| BG hyperplasia | 13 | 3.07 2 4 | 0.8 | |||
a BG = Brunner's gland, b f = Fisher's exact test, c U = Mann-Whitney U test, d H. pylori = Helicobacter pylori, and e SD = standard deviation.